↓ Skip to main content

Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides

Overview of attention for article published in Journal for Immunotherapy of Cancer, May 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
10 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides
Published in
Journal for Immunotherapy of Cancer, May 2019
DOI 10.1186/s40425-019-0595-z
Pubmed ID
Authors

Hanan Besser, Sharon Yunger, Efrat Merhavi-Shoham, Cyrille J. Cohen, Yoram Louzoun

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 20%
Student > Bachelor 6 14%
Student > Ph. D. Student 6 14%
Student > Master 5 11%
Other 2 5%
Other 4 9%
Unknown 12 27%
Readers by discipline Count As %
Immunology and Microbiology 7 16%
Agricultural and Biological Sciences 7 16%
Medicine and Dentistry 4 9%
Computer Science 4 9%
Biochemistry, Genetics and Molecular Biology 3 7%
Other 6 14%
Unknown 13 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2019.
All research outputs
#6,414,093
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,533
of 3,424 outputs
Outputs of similar age
#108,875
of 364,073 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#44
of 68 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,073 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.